to relieve suffering for people with great needs, but few options. We are dedicated to discovering and developing life changing treatments for patients with under addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis and uterine fibroids , as

to relieve suffering for people with great needs, but few options. We are dedicated to discovering and developing life changing treatments for patients with under addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis and uterine fibroids , as

to relieve suffering for people with great needs, but few options. We are dedicated to discovering and developing life changing treatments for patients with under addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis and uterine fibroids , as

to relieve suffering for people with great needs, but few options. We are dedicated to discovering and developing life changing treatments for patients with under addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis and uterine fibroids , as

to relieve suffering for people with great needs, but few options. We are dedicated to discovering and developing life changing treatments for patients with under addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis and uterine fibroids , as

to relieve suffering for people with great needs, but few options. We are dedicated to discovering and developing life changing treatments for patients with under addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis and uterine fibroids , as

to relieve suffering for people with great needs, but few options. We are dedicated to discovering and developing life changing treatments for patients with under addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis and uterine fibroids , as

to relieve suffering for people with great needs, but few options. We are dedicated to discovering and developing life changing treatments for patients with under addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis and uterine fibroids , as

to relieve suffering for people with great needs, but few options. We are dedicated to discovering and developing life changing treatments for patients with under addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis and uterine fibroids , as

to relieve suffering for people with great needs, but few options. We are dedicated to discovering and developing life changing treatments for patients with under addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis and uterine fibroids , as

to relieve suffering for people with great needs, but few options. We are dedicated to discovering and developing life changing treatments for patients with under addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis and uterine fibroids , as

to relieve suffering for people with great needs, but few options. We are dedicated to discovering and developing life changing treatments for patients with under addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis and uterine fibroids , as

to relieve suffering for people with great needs, but few options. We are dedicated to discovering and developing life changing treatments for patients with under addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis and uterine fibroids , as

Leads assessment of developability for gene therapy assets and coordinates with CMC colleagues to communicate risks and mitigation strategies and to transfer research processes and analytical methods In addition to gene therapy work, this role may include contributions to monoclonal antibody and peptide projects from inception to IND enabling studies Maintains broad knowl

to relieve suffering for people with great needs, but few options. We are dedicated to discovering and developing life changing treatments for patients with under addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis and uterine fibroids , as